53 results
424B3
NNMX
NANOMIX Corp
12 Jul 22
Prospectus supplement
8:44pm
in 2020. The increased loss of $3.273 million was largely due to the loss on debt modification, an increase in interest expense, offset by the PPP loan … , offset by a loss on debt modification of $2,385 thousand, and amortization of the discount from the issue of promissory notes of $1,478 thousand
424B3
wxddxqugtgw2yet
17 May 22
Prospectus supplement
6:11am
DEF 14C
2bk5hrmnowy 8x9
20 Oct 21
Information statement
3:43pm
PRE 14C
wee x2yy7atc
9 Sep 21
Preliminary information
4:37pm
8-K/A
EX-99.1
huxq45nwv4 ftf
27 Aug 21
Management’s Discussion and Analysis of Financial Condition and Results of Operations
12:00am
8-K/A
EX-99.2
tk0sausro9cqb73d0uu
27 Aug 21
Management’s Discussion and Analysis of Financial Condition and Results of Operations
12:00am
SC 14F1
zkbzi1z8 wjxscjye
23 Jul 21
Statement regarding change in majority of directors
5:00pm
8-K
EX-10.3
77t15wvkauuaaolpmq
29 Jun 21
Boston Therapeutics Announces $8.4 Million Convertible Placement
9:06am